miércoles, 1 de julio de 2026

PARP Discontinuation Maintains Outcomes in Ovarian Cancer Exceptional Responders Edited by Victoria Stern JAMA Oncol. 2026; doi:10.1001/jamaoncol.2026.1924

https://www.medscape.com/viewarticle/parp-discontinuation-maintains-outcomes-ovarian-cancer-2026a1000mb3?src=

No hay comentarios:

Publicar un comentario